Gilead Sciences has been one of the fastest-growing biotech companies over the past few years. The company’s rocket-like growth trajectory, though, is expected to start slowing starting this year. Should investors be concerned?
Gilead Sciences has been one of the fastest-growing biotech companies over the past few years. The company’s rocket-like growth trajectory, though, is expected to start slowing starting this year. Should investors be concerned?